Management of an 8-Month-Old Infant with Fever, Throat Infection, Wet Cough, and Generalized Weakness (Inpatient)

Clinical Assessment First

• Viral upper + lower respiratory tract infection (most common - RSV, Rhinovirus, Parainfluenza)
• Bronchiolitis (wet cough + fever at this age is classic)
• Bacterial pharyngitis/tonsillitis is very uncommon under 2 years; Group A Strep rarely causes tonsillitis in infants
• Pneumonia must be excluded given wet cough + generalized weakness
• Acute otitis media - screen for, as it commonly co-occurs with RSV

Immediate Inpatient Workup

Note: Routine viral testing does not change management in most cases of bronchiolitis but aids cohorting in hospital - [Red Book 2021, p. 978].

Supportive Management (Cornerstone of Treatment)

1. Airway & Respiratory Support

• Nasal suctioning - clear secretions before feeds; use bulb syringe or mechanical suction
• Supplemental oxygen - only if SpO2 persistently <90%; target SpO2 ≥94%
• Positioning - head-end elevation (30 degrees)
• Nasal saline drops (0.9% NaCl, 2-3 drops per nostril) before feeds to clear the nasal airway
• High-flow nasal oxygen (HFNC) or CPAP in consultation with paediatric intensivist if SpO2 unresponsive

2. Hydration & Feeding

• Maintain hydration - most important intervention
• Offer breastmilk or formula in smaller, more frequent amounts (wet cough + weak suck = fatigue easily)
• If oral intake is insufficient: start IV fluids (10% dextrose in 0.45% saline or maintenance fluids per weight)
• Nasogastric tube feeding if oral feeding is unsafe or inadequate
• Monitor input/output chart strictly

3. Fever Management

• Paracetamol (Acetaminophen): 10-15 mg/kg/dose orally every 4-6 hours (max 5 doses/24 hrs) - drug of choice
• Ibuprofen: 5-10 mg/kg/dose every 6-8 hours - safe in infants >6 months; can alternate with paracetamol
• Tepid sponging if temperature >39.5°C while waiting for antipyretics to act
• Do NOT use aspirin in infants (Reye syndrome risk)
• No cough syrups or antihistamines - ineffective and potentially dangerous in infants

Medications - What to Use and What NOT to Use

Use:

Do NOT Use (evidence-based):

• Beta-agonists (Salbutamol/albuterol) - NOT recommended for RSV bronchiolitis - no benefit ([Red Book 2021, p. 980])
• Corticosteroids - do NOT reduce admissions or length of stay in bronchiolitis ([Red Book 2021, p. 980])
• Antibiotics - NOT indicated for viral bronchiolitis unless concurrent bacterial infection is confirmed (risk of bacterial co-infection is <1%) ([Red Book 2021, p. 980])
• Aerosolized ribavirin - not recommended; no clinically meaningful benefit
• Nebulized epinephrine - insufficient data; not routinely recommended
• OTC cough suppressants, decongestants, antihistamines - contraindicated in infants

Antibiotics: When TO use them

• CXR shows consolidation (pneumonia) - use Amoxicillin 40-45 mg/kg/day PO or IV
• Blood culture grows a pathogen
• Confirmed Group A Strep throat (rare at this age)
• Confirmed acute otitis media with bulging tympanic membrane

Monitoring Parameters (Inpatient)

Warning Signs - Escalate Immediately

• SpO2 <90% despite O2
• Apneic episodes or labored breathing
• Signs of dehydration (sunken fontanelle, dry mucous membranes, no tears)
• Altered consciousness or severe lethargy
• Temperature >39.5°C not responding to antipyretics

Infection Control (Important for Hospital)

• Place infant in a single room or cohort with other RSV patients
• Contact + droplet precautions: gown, gloves, surgical mask for all staff
• RSV survives on surfaces up to 6 hours - strict hand hygiene
• Viral shedding can last 3-8 days (up to weeks in infants) - [Red Book 2021, p. 978]

Expected Course & Prognosis

• Viral bronchiolitis typically peaks at days 2-5, then gradually improves over 7-10 days total
• Most previously healthy infants recover fully with supportive care
• A small proportion (<5%) may need escalation to PICU/ventilation
• Generalized weakness usually reflects fever burden, poor feeding, and viral illness - improves with hydration and antipyretic control